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Edited by Veli-Pekka LehtoAbstract To investigate whether hepatic stellate cells (HSCs)
alter their expression of MMPs after exposure to nitrogen oxide
intermediate (NOI), a human hepatic stellate cell line, LI90
cells, was stimulated with an NO donor, SNAP, or a peroxyni-
trite donor, SIN-1, and the culture supernatants were analyzed
by gelatin zymography or anti-MMPs immunoblot. Although
SIN-1 did not enhance the secretions of MMP-1 and 13, SIN-
1 induced the NF-jB activation, MT1-MMP expression and
the secretion of activated MMP-2 in LI90 cells. These results
suggest that peroxynitrite may contribute to the remodeling of
the extracellular matrix in liver by activating pro-MMP-2.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Liver ﬁbrosis occurs following most chronic liver injuries and
results from changes in the balance between the synthesis and
degradation of extracellular matrix (ECM) components [1,2].
Hepatic stellate cells (HSCs) play a pivotal role in the cellular
and molecular events that lead to ﬁbrosis [3]. Following liver in-
jury, these cells undergo changes toward a myoﬁbroblastic-like
phenotype and secrete extracellular matrix components [4]. In
addition, activated HSCs are involved in ECM degradation
by providing MMPs [5]. During liver ﬁbrogenesis, a number
of MMPs, such as MMP-1, MMP-2, and MMP-13, are ex-
pressed in the liver by hepatic stellate cells [6]. Therefore, it
has been suggested that the activation mechanism of HSCs
and the secretion of MMPs may contribute to the process of li-
ver ﬁbrosis [7].
Evidence of oxidative stress has also been detected in clinical
condition of liver ﬁbrosis with diﬀerent etiology [8]. It has be-
come obvious that an increase in the levels of reactive oxygenAbbreviations: ECM, extracellular matrix; HSCs, hepatic stellate cells;
IjB-a, IkappaB-a; MAPK, mitogen activated protein kinase; MMP,
matrix metalloproteinases; SEAP, secretory alkaline phosphatase;
SNAP, S-nitroso-N-acetyl-DL-penicillamine; SIN-1, N-morpholino
sydnonimine hydrochloride
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doi:10.1016/j.febslet.2005.04.071species (ROS) occurs in the process of liver ﬁbrosis [9]. ROS
may represent direct or indirect pro-ﬁbrogenic stimuli for
HSCs [10]. Moreover, signs of oxidative stress and lipid perox-
idation are concomitant or precede HSCs activation and colla-
gen deposition [11]. It was demonstrated that HSCs express
non-phagocytic NADPH oxidase and inducible NO synthase
(iNOS) [12], which generate superoxide and NO, once exposed
to eﬀective stimuli. Furthermore, the simultaneous production
of NO and superoxide by HSCs or Kupﬀer cells in liver may
lead to the generation of peroxynitrite (ONOO) [13]. The
present study was designed to more clearly elucidate the bio-
logical eﬀects elicited by oxidative stress on HSCs. In particu-
lar, we investigated whether nitrogen oxide intermediate (NOI)
may aﬀect the synthesis of MMPs and their related inhibitors
(TIMP-1 and TIMP2) in HSCs.2. Materials and methods
2.1. Reagents
An NO donor, SNAP (S-nitroso-N-acetyl-DL-penicillamine), and a
peroxynitrite donor, SIN-1 (N-morpholino sydnonimine hydrochlo-
ride), were purchased from Dojindo Laboratories (Kumamoto,
Japan). Mouse anti-human membrane-type 1 matrix metalloprotein-
ase (MT1-MMP) monoclonal antibody and mouse anti-human tissue
inhibitor metalloproteinase–1 (TIMP-1) and TIMP-2 antibodies were
obtained from Fuji Chemical Co. (Takaoka, Japan). Mouse mono-
clonal anti-a-smooth muscle actin antibody was purchased from
Novacastra Laboratories (Newcastle, UK). Mouse monoclonal
anti-nitrotyrosine antibody (1A6) was purchased from UBI (Lake
Placid, USA). Puriﬁed pro-MMP-2 was purchased from Calbiochem
(San Diego, USA). Activation with p-aminophenylmercuric acetate
(APMA, Sigma Chemical) was done by incubation of puriﬁed
pro-MMP-2 with 1 mM APMA at 37 C for 15 min [14]. All other
reagents were purchased from Sigma Chemical Co. (St. Louis, MO).
2.2. Cells
LI90 cells, human HSCs established by Dr. Murakami, were pur-
chased by JCRB (Japanese Collection of Research Bioresources, Osa-
ka, Japan). Cells were propagated in Dulbeccos minimal essential
medium (DMEM) supplemented with 10% fetal calf serum (Gibco
BRL, Gaithersburg, MD). LI90 cells were stimulated with SIN-1 at
diﬀerent concentrations (0–500 lM) for 24 h in serum-free DMEM.
Culture supernatants were subjected to the analysis for gelatin zymog-
raphy or immunoblot.
2.3. Gelatin zymography
LI90 cells-conditioned culture media (serum-free) were incubated at
37 C for 20 min in sodium dodecyl sulfate (SDS) sample buﬀer free of
reducing agents and then electrophoresed on 8% polyacrylamide gels
containing 0.5 mg/ml gelatin at 4 C. After electrophoresis, gels wereblished by Elsevier B.V. All rights reserved.
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50 mM Tris–HCl buﬀer (pH 7.5) containing 0.15 M NaCl, 10 mM
CaCl2, and 0.02% NaN3 for 16 h at 37 C, and stained with 0.1% Coo-
massie Blue R250.2.4. Immunoblot analysis
The expression of MT1-MMP on LI90 cells and the secretions of
MMP-1, MMP-13 and TIMPs from synovial cells were analyzed by
immunoblot. For this purpose, cells were washed with cold PBS and
lysed by the addition of a lysis buﬀer containing 1% Nonidet P-40,
50 mM Tris (pH 7.5), 100 mM NaCl, 5 mM EDTA, 10 lg/ml apro-
tinin, and 10 lg/ml leupeptin for 20 min at 4 C. Insoluble materials
were removed by centrifugation at 1500 · g for 15 min at 4 C. The
supernatant was saved and the protein concentration was deter-
mined using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA).
An identical amount of protein (30 lg) from each lysate or the cul-
ture supernatant was subjected to 8% SDS–polyacrylamide gel elec-
trophoresis (PAGE). The fractionated proteins were transferred to
nitrocellulose membranes (Amersham, Arlington Heights, IL), and
the ﬁlters were blocked for 1.5 h using non-fat dried milk in Tris-
buﬀered saline (TBS: 50 mM Tris, 0.15 M NaCl, pH 7.5) containing
0.1% Tween 20, washed with TBS, and incubated at room temper-
ature for 2 h at a 1:150 dilution of mouse anti-MT1-MMP or
MMPs monoclonal antibodies (mAb). The membranes were further
incubated with a 1:2000 dilution of horseradish peroxidase-
conjugated donkey anti-mouse immunoglobulin G (IgG) antibody
(Promega, Madison, WI) for 20 min. An enhanced chemilumines-
cence (ECL) system (Amersham) was used for detection. The blots
were analyzed by densitometer (Fuji Film, Tokyo, Japan). Images
from densitometer were transferred to a personal computer and ana-
lyzed using Science Lab software (Fuji Film). The density of the tar-
get protein band of untreated cells was assigned the value of 1.0 and
each result was calculated as relative units.2.5. RNA preparation and quantitative PCR assay
Total cellular RNA was extracted from LI90 cells using guani-
dium thiocyanate and phenol (RNAzol B, Cinna/Biotek Labs Int.
Inc., Friendswood, TX). First-strand cDNA was synthesized by re-
verse transcription at 45 C for 45 min in a 50 ll reaction mixture
containing 1 lg of total RNA and MuLV reverse transcriptase
(Invitrogen). After denaturing at 99 C for 5 min followed by cool-
ing at 5 C, the cDNA was ampliﬁed using PCR. The quantiﬁcation
of MT1-MMP transcripts in LI90 cells was carried out with the
LightCycler PCR system (Roche Diagnostics, Meylan, France) using
the DNA binding SYBR Green I dye for the detection of PCR
products. A serial dilution was used to generate each standard
curve. For real time quantitative PCR, each reaction contained:
1· of LightCycler-DNA master SYBR Green I, speciﬁc primer
(Roche), and 2 ll of cDNA matrix, in a ﬁnal volume of 20 ll. After
2 min of denaturation at 95 C, the reactions were cycled 40 times
for 5 s at 95 C, 10 s at the annealing temperature, and 15 s or 7 s
at 72 C for MT1-MMP and GAPDH, respectively. Product speci-
ﬁcity was determined by melting curve analysis as described in the
LightCycler handbook. The amount of transcripts in each sample
is given as copy number. The results are expressed as ratios of
MT1-MMP transcripts to GAPDH transcripts.Fig. 1. Eﬀects of SNAP on gelatinase secretions from LI90 cells. LI90
cells were cultured with SANP in serum-free culture media for 24 h.
The conditioned media were analyzed by gelatin zymography. The
data shown are representatives of at least three independent
experiments.2.6. Plasmids and transfection
pNFjB-SEAP (CLONTECH Laboratories, Inc., Palo Alto, CA)
is designed to monitor the activation of NF-jB and NF-jB-medi-
ated signal transduction pathways. pNFjB-SEAP contains four tan-
dem copies of the jB4 enhancer fused to the HSV-TK promoter.
pTAL-SEAP (CLONTECH Laboratories) was used as a negative
control to determine the background signals associated with the cul-
ture medium. Cells were grown to approximately 50% conﬂuence on
30-mm plates. Transfections were done using the calcium phosphate
reagents and following the manufacturers instructions (CLON-
TECH Laboratories), and cells were treated as described above.
Chemiluminescence detection of SEAP activity was performed
according to the manufacturers instructions (CLONTECH Labora-
tories) using a plate ﬂuorometer (Berthold, Bad Wildbach,
Germany).2.7. Statistical analysis
Diﬀerences in the data were analyzed by 1-way ANOVA combined
with the Bonferronis test, and all values were expressed as
means ± S.D. The diﬀerences between groups were considered to be
signiﬁcant at P < 0.05.3. Results
The eﬀects of NO to human hepatic stellate cells were inves-
tigated by incubating LI90 cells with an NO donor, SNAP,
which generates NO in vitro. As shown in Fig. 1, SNAP treat-
ment did not modulate the gelatinase secretions from LI90
cells. Next, we incubated the cells with SIN-1, which generates
ONOO by releasing NO and O2 simultaneously for 24 h and
the culture supernatants were subjected to gelatin zymography.
SIN-1 was not toxic to LI90 cells at the concentrations
(500 lM) used in this experiment (data not shown). Gelatin
zymography demonstrated that in addition to the secretion
of a late form of MMP-2 (Mr = 72 kd), the activated form of
MMP-2 (Mr = 66 kd) was detected when LI90 cells were trea-
ted with SIN-1 (Fig. 2A and B). This gelatinolytic band with
lower molecular weight (Mr = 66 kd) was similar to APMA-
activated MMP-2 in that it migrated at 66 kd (Fig. 2C). Also,
these gelatinolytic activities were completely inhibited by
EDTA demonstrating that these are metalloproteinases (Fig.
2D). In contrast, the SIN-1 treatment did not signiﬁcantly af-
fect the secretion of MMP-1 (Fig. 3A and B) and MMP-13
(Fig. 3C and D).
It was demonstrated that peroxynitrite is capable of degrad-
ing TIMP-1, a process which could potentiate MMP-2 activa-
tion [15]. Therefore, we examined the eﬀects of SIN-1 on
TIMP-1 secretion from LI90 cells. The molecular forms of
TIMP-1 and its secretion levels were not aﬀected by SIN-1
treatment (Fig. 3E and F). TIMP-2 was not detected in
LI90-conditioned media with or without SIN-1 treatment by
anti-TIMP-2 immunoblot analysis (data not shown).
Because peroxynitrite has the functional property of induc-
ing nitration, we examined whether SIN-1-treated cells contain
proteins with nitrated tyrosine residues [16]. The level of tyro-
sine nitration was clearly increased after 4 h of treatment with
SIN-1. This eﬀect was smaller in SNAP-treated LI90 cells (Fig.
4A). Expression of a-smooth muscle actin (a-SMA) is consid-
ered as an indicator of HSCs activation [17]. The expression of
a-SMA was also examined using LI90 cells treated with SIN-1
Fig. 2. Eﬀects of SIN-1 on gelatinase secretion from LI90 cells.
(A) LI90 cells were cultured with various concentrations of SIN-1 in
serum-free culture media for 24 h. The conditioned media were
analyzed by gelatin zymography. Note the activated MMP-2 with
lower molecular weights in addition to 72 Kda MMP-2 in the SIN-1-
treated LI90 cells-conditioned media. (B) Densitometric analysis of A
is presented as the relative ratio of active form/pro-form of MMP-2.
These data represent means ± S.D. of three independent experiments.
\P < 0.01 versus untreated LI90 cells. (C) Gelatinolytic activity of LI90
cells-conditioned media detected by zymography. Lane 1: untreated
LI90 cells-conditioned media, Lane 2: SIN-1 (500 lM)-treated LI90
cells-conditioned media, Lane 3: puriﬁed pro-MMP-2 standards
(20 ng), Lane 4 pro-MMP-2 standards (20 ng) were activated with
1 mM APMA at 37 C for 15 min. The data shown are representatives
of at least three independent experiments. (D) LI90 cells were cultured
with SIN-1 in serum-free culture media for 24 h. Zymogram of LI90
cells-conditioned media was incubated in the presence or absence of
EDTA (10 mM) for 16 h at 37 C. Gelatinolytic activities were
completely inhibited by EDTA. Fig. 3. Eﬀects of SIN-1 on MMPs or TIMP-1 secretions from LI90
cells. LI90 cells were cultured with various concentrations of SIN-1 for
24 h. The conditioned media were analyzed by anti-MMP-1 (A),
MMP-13 (C), and TIMP-1 (E) immunoblot. MMP-1 (B), MMP-13 (D)
and TIMP-1 (F) bands were calculated as a relative unit by
densitometer. The band of untreated cells was assigned the value of
1.0 and data were expressed as the relative units. These data represent
means ± S.D. of three independent experiments. \P < 0.01 versus
untreated LI90 cells.
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expression on LI90 cells (Fig. 4B and C).
As shown in Fig. 5, the incubation of LI90 cells-conditioned
media containing pro-MMP-2 with SIN-1 for 24 h did not re-
sult in the activation of pro-MMP-2. This result indicates that
SIN-1-induced pro-MMP-2 activation requires the presence of
pro-MMP-2 producing IL90 cells. It has been suggested that
the conversion of pro-MMP-2 to active MMP-2 requires cell
membrane-associated processing by membrane-type matrixmetalloproteinase (MT-MMP) [18]. Therefore, we examined
whether MT-MMP is involved in the SIN-1-induced pro-
MMP-2 activation. LI90 cells were cultured with SIN-1 for
Fig. 4. (A) Tyrosine nitration in LI90 cells. Immunoblot analysis of
LI90 cells extracts with anti-nitrotyrosine antibody showed SIN-1
induced tyrosine nitration on several proteins. Immunoblot analysis of
a-smooth muscle actin expression in LI90 cells. (B) LI90 cells were
treated with SIN-1 or SNAP with the indicated concentrations for
24 h. Cellular lysates were analyzed by immunoblot using anti-a-
smooth muscle actin antibodies. (C) Bands of a-smooth muscle actin
were calculated as a relative unit by densitometer. The band of
untreated cells was assigned the value of 1.0 and data were expressed as
the relative units. These data represent means ± S.D. of three
independent experiments. \P < 0.01 versus untreated LI90 cells.
Fig. 6. MT1-MMP expression in SIN-1-treated LI90 cells. (A) LI90
cells were cultured with various concentrations of SIN-1 for 24 h. The
cells were lysed and equal amounts of cellular lysates were analyzed by
immunoblot using antibodies to human MT1-MMP. The band of
MT1-MMP of untreated cells was assigned the value of 1.0 and data
were expressed as the relative units. (B) MT1-MMP bands were
calculated as a relative unit by densitometer. The band of untreated
cells was assigned the value of 1.0 and data were expressed as the
relative units. These data represent means ± S.D. of three independent
experiments. \P < 0.01 versus untreated LI90 cells.
3122 K. Migita et al. / FEBS Letters 579 (2005) 3119–312524 h. The cells were lysed and the lysates were subjected to
immunoblot using anti-MT1-MMP antibodies. As shown in
Fig. 6, MT1-MMP was barely detected in unstimulated LI90
cells and the intensity of MT1-MMP band was increased when
the LI90 cells were treated with SIN-1. We also analyzed MT1-
MMP mRNA expression by real-time quantitative RT-PCR
analysis. As shown in Fig. 7, MT1-MMP mRNA expression
in LI90 cells was increased by SIN-1 treatment. This SIN-1-in-
duced MT1-MMP expression was parallel to the induction ofFig. 5. In vitro eﬀects of SIN-1 on gelatinase. LI90 cells-conditioned
media were incubated with SIN-1 for 24 h at 37 C. Incubated media
were analyzed by gelatin zymography. The data shown are represen-
tatives of at least three independent experiments.activated form of MMP-2 in SIN-1-treated LI90 cells-condi-
tioned media (Fig. 2A and B).
We further investigated the peroxynitrite-mediated signaling
pathway in LI90 cells. We examined the eﬀects of SIN-1 on the
state of ERK1/2, p38 and JNK1/2. The state of phosphoryla-
tion of these MAPKs was examined by immunoblot using
anti-phospho-speciﬁc MAPKs antibodies. The phosphoryla-
tion of ERK1/2, p38 and JNK1/2 was not increased but rather
decreased in SIN-1-treated LI90 cells (Fig. 8A–F). Immuno-
blot of b-actin is shown as a control for equal loading of sam-
ples (Fig. 8G). We also evaluated IjB-a proteolysis. The
protein levels of IjB-a in SIN-1-treated LI90 were measured
by immunoblot analysis (Fig. 9A and B). The SIN-1Fig. 7. MT1-MMP mRNA expression in SIN-1-treated LI90 cells.
LI90 cells were stimulated by SIN-1 for 6 h. Total cellular RNA was
analyzed by real-time RT-PCR using speciﬁc primers for MT1-MMP.
Results are means of three separate experiments. \P < 0.01 versus
untreated LI90 cells.
Fig. 8. Eﬀects of SIN-1 on the MAP kinase phosphorylation of LI90 cells. LI90 cells were stimulated by SIN-1 (500 lM) for indicated times. Equal
amounts of cellular lysates were analyzed by immunoblot using anti-phospho-speciﬁc ERK1/2 (A), p38 (C), JNK1/2 (E) and b-actin (G) antibodies.
Bands of ERK1/2 (B), p38 (D), and JNK1/2 (F) were calculated as a relative unit by densitometer. The band of untreated cells was assigned the value
of 1.0 and data were expressed as the relative units. These data represent means ± S.D. of three independent experiments. \P < 0.01 versus untreated
LI90 cells.
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dependent manner, suggesting the activation of NF-jB in
LI90 cells. However, the SNAP treatment did not aﬀect the
protein levels of IjB-a. To determine whether SIN-1 treatment
modulates the transcriptional activity of NF-jB, LI90 cells
were transiently transfected with a reporter gene construct,
pNFjB-SEAP. Cells were subsequently treated with SIN-1,
and SEAP in the culture supernatants was assayed. As shown
in Fig. 10A, SIN-1 treatment increased the SEAP levels com-
pared to those of control cells. SNAP treatment did not acti-
vate the NF-jB transcriptional activity (Fig. 10B).4. Discussion
Hepatic stellate cells (HSCs) play a central role in the devel-
opment of liver ﬁbrosis [3]. After chronic liver injury, HSCs
proliferate and transform into myoﬁbroblastic cells (activated
HSCs) that are the major source of collagens that accumulatein the ﬁbrotic liver [4]. This process is promoted by a variety of
cytokines and soluble factors released by Kupﬀer cells and
inﬂammatory cells as well as HSCs [19]. Mayoral et al. [20]
demonstrated an increased hepatic expression of iNOS in bile
duct ligated rats, model animals for hepatic ﬁbrosis. Further-
more, stimulation of NO synthesis with L-arginine treatment
augmented hepatic ﬁbrosis. These results suggest that NO
may be involved in the development of ﬁbrosis. We found that
peroxynitrite induces the secretion of activated MMP-2 in cul-
tured human HSCs.
A number of studies have emphasized the proﬁbrogenic
functions of MMP-2 [21,22]. However, the exact mechanisms
leading to MMP-2 activation have not been clearly delineated.
The MMPs activity is closely regulated at 3 levels, namely gene
transcription, proteolytic activation, and inhibition by endog-
enous inhibitors [23]. As well, proteolytic activation of MMP-2
is induced by membrane-type MMPs (MT-MMP) [24]. Previ-
ous reports suggest that MT1-MMP-activated MMP-2 exerted
a proﬁbrogenic role during hepatic ﬁbrosis [25]. It is possible
Fig. 9. SIN-1 stimulated IjB-a degradation in LI90 cells. (A) LI90
cells were stimulated with SIN-1 (500 lM) and SNAP (500 lM) for the
indicated times. Cells were lysed and the cellular lysates were assessed
by anti-IjB-a immunoblot analysis. (B) Bands of IjB-a were calcu-
lated as a relative unit by densitometer. The band of untreated cells
was assigned the value of 1.0 and data were expressed as the relative
units. These data represent means ± S.D. of three independent
experiments. \P < 0.01 versus untreated LI90 cells.
Fig. 10. SEAP expression of LI90 cells transfected with pNFjB-
SEAP. LI90 cells were transfected with pNFjB-SEAP and a control
plasmid, pTAL-SEAP, and stimulated with SIN-1 (A) or SNAP (B) for
indicated time. SIN-1 treatment signiﬁcantly increased SEAP expres-
sion in pNFjB-SEAP-transfected LI90 cells. Columns represent
means ± S.D. of data obtained from three independent and duplicate
experiments. \P < 0.01 versus untreated LI90 cells.
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and induces its enzymatic activation. However, SIN-1 did not
activate pro-MMP-2 in the absence of HSCs in vitro, suggest-
ing that the interaction between peroxynitrite and HSCs is re-
quired for this MMP-2 activation.
The hepatic expression of MMP-2 and MT1-MMP is in-
creased in human ﬁbrotic livers, and activated HSCs have been
identiﬁed as a source of both proteins [26,27]. Therefore, we
investigated whether the SIN-1 treatment increases MT1-
MMP expression in HSCs. Our data showed that MMP-2 acti-
vation in SIN-1-treated HSCs is associated with the increased
expression of MT1-MMP by these cells. In response to perox-
ynitrite, HSCs may express MT1-MMP on their surface there-
by stimulating pro-MMP-2 activation. The mechanism leading
to MT1-MMP expression in SIN-1-treated HSCs is not
known. The ﬁnding that SIN-1 leads to the rapid degradation
of IjB-a suggests that the peroxynitrite may activate NF-jB in
HSCs. It can be speculated that the peroxynitrite-mediated
NF-jB dependent pathway might be involved in the MT1-
MMP induction as reported previously [28,29].
Oxidative stress has been detected in ﬁbrotic liver and acts as
a mediator of the ECM remodeling responsible for liver ﬁbro-
sis [30]. In liver injury, iNOS is upregulated in liver cell popu-
lations including HSCs, and the NO generation is increased
[31]. The pathogenic action of NO seems to occur as the inter-
action of NO with O2 to generate peroxynitrite. The eﬀects of
peroxynitrite can be deleterious, since it induces the oxidation
and nitration of biological macromolecules [32]. Our data sug-
gest that peroxynitrite may activate MMP-2 secreted from
HSCs by inducing MT1-MMP. ECM remodeling in ﬁbrotic li-
ver could be accelerated by MMP-2 activation, because this en-
zyme degrades the normal subendothelial matrix, hastening its
replacement by collagens [33]. The result of this investigation
may help to elucidate the mechanism by which oxidative stress
activates MMP-2 in the development of liver ﬁbrosis.In conclusion, our study shows that peroxynitrite pro-
motes the activation of MMP-2 secreted by human hepatic
stellate cell (HSC) line and that this activation is at least
in part a result of MT1-MMP induction. These ﬁndings sug-
gest that oxidative stress represents pro-ﬁbrogenic stimuli for
HSCs leading to MT1-MMP expression, thereby stimulating
MMP-2 activation and ECM remodeling in hepatic ﬁbrosis
development.
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